Cassiopea Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Cassiopea General Information

Description

Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It is focused on developing and commercializing differentiated medical dermatology products. The company's focus is on the topical treatment of acne; Androgenic Alopecia, (or AGA); and genital warts. Its portfolio comprises four unencumbered clinical candidates namely: Winlevi, for the treatment of acne; Breezula, for the topical treatment of AGA; CB-06-02, for the treatment of genital warts; and CB-06-01, for the treatment of acne.

Contact Information

Formerly Known As
Cosmo Dermatos
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 6265 Greenwich Drive
  • Suite 210
  • San Diego, CA
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Former Stock Listing
SKIN
Corporate Office
  • 6265 Greenwich Drive
  • Suite 210
  • San Diego, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cassiopea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cassiopea‘s full profile, request access.

Request a free trial

Cassiopea Patents

Cassiopea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026087531-A1 Clascoterone formulations and methods of use thereof Pending 22-Oct-2024
WO-2026057588-A1 Clascoterone and minoxidil combination therapy for use in treating hair loss Pending 10-Sep-2024
FR-3159750-A1 Method for monitoring a state of sports fitness Inactive 29-Feb-2024
WO-2025172818-A1 Pyrilutamide combination therapy Pending 14-Feb-2024
EP-4823584-A1 Cortexolone-17alpha-propionate combinations for treating acne Pending 14-Dec-2023 A61P17/10
To view Cassiopea’s complete patent history, request access »

Cassiopea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cassiopea FAQs

  • When was Cassiopea founded?

    Cassiopea was founded in 2013.

  • Where is Cassiopea headquartered?

    Cassiopea is headquartered in San Diego, CA.

  • What is the size of Cassiopea?

    Cassiopea has 11 total employees.

  • What industry is Cassiopea in?

    Cassiopea’s primary industry is Drug Discovery.

  • Is Cassiopea a private or public company?

    Cassiopea is a Private company.

  • What is the current valuation of Cassiopea?

    The current valuation of Cassiopea is .

  • What is Cassiopea’s current revenue?

    The current revenue for Cassiopea is .

  • When was Cassiopea acquired?

    Cassiopea was acquired on 17-Dec-2021.

  • Who acquired Cassiopea?

    Cassiopea was acquired by Cosmo Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process